Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2006 Nov;59(11):1151-9.
doi: 10.1136/jcp.2005.031195.

Demyelinating diseases

Affiliations
Review

Demyelinating diseases

S Love. J Clin Pathol. 2006 Nov.

Abstract

A diagnosis of demyelination carries important therapeutic and prognostic implications. In most cases the diagnosis is made clinically, and involvement of the histopathologist is largely confined to postmortem confirmation and clinicopathological correlation. However, every now and then, accurate diagnosis of the presence or cause of demyelination before death hinges on the histopathological assessment. Recognition of demyelination depends on an awareness of this as a diagnostic possibility, and on the use of appropriate tinctorial and immunohistochemical stains to identify myelin, axons and inflammatory cells. In biopsy specimens, the critical distinction is usually from ischaemic or neoplastic disease, and the types of demyelinating disease most likely to be encountered are multiple sclerosis, acute-disseminated encephalomyelitis, progressive multifocal leucoencephalopathy and extrapontine myelinolysis. Interpretation of the pathology has to be made in the context of the clinical, radiological and biochemical findings. Freezing of a small amount of fresh tissue allows for later virological studies, and electron microscopy is occasionally helpful for demonstration of viral particles.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None.

References

    1. Kenealy S J, Pericak‐Vance M A, Haines J L. The genetic epidemiology of multiple sclerosis. J Neuroimmunol 20031437–12. - PubMed
    1. Sadovnick A D, Dircks A, Ebers G C. Genetic counselling in multiple sclerosis: risks to sibs and children of affected individuals. Clin Genet 199956118–122. - PubMed
    1. Pugliatti M, Sotgiu S, Rosati G. The worldwide prevalence of multiple sclerosis. Clin Neurol Neurosurg 2002104182–191. - PubMed
    1. Rosati G. The prevalence of multiple sclerosis in the world: an update. Neurol Sci 200122117–139. - PubMed
    1. Kurtzke J F. Multiple sclerosis in time and space—geographic clues to cause. J Neurovirol 20006(Suppl 2)S134–S140. - PubMed

MeSH terms